Research
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis — in some cases even redirecting the course of care.
Latest stories
Discovery Science
June 20, 2024
Individualized Medicine
June 5, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community